The infiltration of Tex expressing CD8/PDCD1/TIM3/LAG3 in localized ccRCC can identify the patients with worse prognosis to benefit from adjuvant therapy (Giraldo et al., 2017). This evidence concerns the gene PDCD1 and nonpapillary renal cell carcinoma.